By comparing them with classic HER2 negative group (ASCO/CAP Group 5, average HER2 signal < 4.0 per cell and HER2/CEP17 ratio < 2.0), we hope to provide some insights into their actual similarity to HER2-negetive breast cancers. Here, ERBB2 is linked to breast carcinoma.